Introduction
The current knowledge of the etiology or even of the pathogenesis of glomerulonephritis is too limited to be of much value. At the present time, the best diagnosis are based on renal biopsy. Various in vitro tests are used to investigate the status of cell mediated immunity (CMT) in this disease e. g. proliferation test, lymphokine test and phenotypic characterization of eell population test. Those results are still controversial. Recently . an increased neopterin excretion was found in patients suffering from the diseases associated with the activation of CM I e. g. during allograft rejection (1), infections with virus (2). intracellular bacteria (3) and parasite (4). Thus. neopterin appears to be a potential indicato r of the activation of CMI. In order to get more relevant information on the pathogenic mech a nism of glomerulonephritis. we determined urinary neopterin le vels in these patients.
Material and Methods

Patien ts
There were 85 glomerulonephritis patients without renal insufficiency. age range from 20 -50 years. Thirty cases were systemic lupus erythrematosus (SLE), 10 cases were focal segmental glomerulosclerosis (FSGS). 12 cases were 1GM nephropathy. 8 cases were membranous and 25 cases were IgA nephropathy. The differential diagnosis was based on renal biopsy. Urine samples were ta ken during the initial Pterid ines Vol. 2 No.2 Copyright ( Il)l) I Wa lter de Gru yter . Berlin ' New York pa tient examination a few days before or after ren a l biopsy.
Controls
The first morning urine sa mples were taken from 222 apparently healthy Thai people; 136 of females and 86 of males. Age ranged from 18 -55 years.
Measurement of neopterin: Urinary neopterin and creatinine were measured by high pressure liquid cl1fo-matography on reversed phase. The previo us method (5) was modified for use with Spectra Physics HPLC system. The neopterin level was expressed as urinary neopterin/crea tinine ra tio (nmol/ mmol). Figure 1 shows the results of neopterin levels in patients and controls. The neopterin levels in health y Thai people are 130 ± 43 for females and 102 ± 34 for males. The mean neopterin level was 1117 ± 306 in SLE. 498 ± 47 in FSGS and 308 ± 52 in IgM nephropath y patients. They were significantly higher than that of th e controls (p < 0.001) in all three groups. The neopterin levels in membranous (129 ± 11) and IgA nephropathy (131 ± 26) were not differ from healthy controls. In inactive SLE patients. the neopterin level during follow up period dropped to normal or slightl y increa ses (240 ± 75). As shown in Figure 2 . the neopterin levels did not correlate with nephrotic syndrome or proteinuria. . r--- The present study shows significantly increased neopterin levels up to 10 fold, 5 fold and 3 fold when compared to healthy subjects in patients with SLE, FSGS and IgM nephropathy respectively. Since increased neopterin level reflects the activation of CMI , therefore it should confirm the pathogenesis involving CMI mechanism in these diseases. This finding is in agreement with in vitro observations (6, 7). Increased urinary neopterin level has been found in rheumatoid arthritis and systemic lupus erythrematosus patients (8) . It is of interest, that 5 SLE patients with clinical signs of no arthritis and no nephrotic syndrome had normal or slightly increased neopterin levels. This suggested that serial measurement of neopterin should be of great value for indicating the disease activity.
Results
There was large variation of mean neopterin level in the individual disease. The different of neopterin level between FSGS (with NS) and IgM nephropathy (with NS) may be helpful to confirm the differential diagnosis when the renal pathology can not be obtained. However, the reason of normal neopterin level in membranous nephropathy (with NS) patients is unknown. Since a small number of the patients studied, a definite conclusion can not be made. .1: Figure 2 . Urinary neopterin in glomerulonephriti s patients with proteinuria and nephrotic syndrome Finally, the normal neopterin level observed in IgA nephropathy is similar to in vitro studies (9, 10) . All patients in this study showed no nephrotic syndrome. Since nephrotic syndrome is rarely seen in IgA nephropathy, the finding of normal neopterin leve l in patients with proteinuria plus hematuria may be guideline to confirm the diagnosis.
This preliminary study allows us to put forward to use neopterin determination as a diagnostic parameter. Further studies along this route including assessment of the urinary neopterin level in differential diagnosis of the disease are required .
